Skip to main content
  • Emily Deichsel, current T32, and Amanda Driscoll, 2019-2020 T32

    SANTE training team, Koutiala, Mali

APPLY NOW

Please Note: Applications are reviewed annually between January - March for the upcoming training periods. Training periods currently run from July 1 – June 30.


Meet our 2020-2021 T32 Fellows

Emily Deischel

Emily Deichsel, PhD

Emily is a post-doctoral fellow interested in pediatric acute infections, maternal health, and childhood growth among vulnerable populations.

For her fellowship Emily will be working with mentor Karen Kotloff, MD, Professor of Pediatrics, Head of Pediatric Infectious Disease and Tropical Medicine, and Associate Director of CVD on a large randomized trial titled “Sauver avec l’AzithromyciNe en Traitant les femmes Enceintes et les enfants (SANTE).” The trial tests efficacy of oral azithromycin delivered in pregnancy and early infancy to prevent stillbirth and infant mortality in Mali, West Africa. Her T32 project will assess the impact of co-administration of azithromycin with routine vaccinations on vaccine immune response in infants enrolled in the trial.

Emily received her PhD in Epidemiology from the University of Washington School of Public Health, an MPH from the University of California, Los Angeles, and a BA in chemistry from Lewis & Clark College.


Elizabeth Hammershaimb

Elizabeth ("AD") Hammershaimb

AD previously worked as a post-baccalaureate intramural research fellow at the National Institutes for Allergy and Infectious Diseases studying Plasmodium falciparum, evaluating parasite-derived proteins expressed on the surface of human red blood cells, and the human immune response to CpG vaccine adjuvants. As a T32 training fellow at CVD, under the dual mentorship of James Campbell, MD, MS, Professor of Pediatrics, and Matthew Laurens, MD, MPH, Associate Professor of Pediatrics and of Medicine, and Director of the Pediatric Infectious Diseases Fellowship Program, she will help conduct a Phase I clinical trial of a CpG-adjuvanted anthrax vaccine and engage in clinical and translational research activities related to COVID-19 vaccines and vaccine uptake.

AD received her Bachelor's of Science in Foreign Service (BSFS) in International Politics from Georgetown University,  her MS in Biotechnology with a concentration in biodefense from Johns Hopkins University, and her MD from Drexel University. She completed her pediatric residency training at Inova Children's Hospital and is currently a pediatric infectious diseases fellow in the Department of Pediatrics Division of Infectious Diseases and Tropical Pediatrics.


Jerilyn-Izac-Jude

Jerilyn Izac

Jerilyn joined CVD as a Postdoctoral Fellow in October, 2020. Her dissertation project worked towards developing a human Lyme disease vaccine. As a T32 training fellow at CVD, under the mentorship of Dr. Bob K. Ernst, she seeks to elucidate the mechanism of action and pharmaceutical application for two TLR4 mimetic adjuvants, BECC438 and BECC470. The former is being investigated through a development contract using a Yersinia pestis challenge model awarded through the NIAID, NIH, Department of Health and Human Services. BECC470 is part of a large collaborative grant with Dr. Matthew Frieman's lab involving an Influenza vaccine. She is most interested in vaccinology and immunology.

Jerilyn received her BS in Biochemistry from Virginia Tech and her PhD in Microbiology and Immunology at Virginia Commonwealth University.

 


Susan Portillo

Susana Portillo, PhD

Susana joined the CVD as a Postdoctoral Fellow in July 2020. She will be focusing on maternal-infant immunity under the mentorship of Dr. Marcela Pasetti. Her work will include evaluating qualitative and functional aspects of immune responses to Tetanus, Diphtheria and acellular Pertussis (TdaP) in pregnant women as well as the impact of maternal immunity on infant immune responses to routine vaccines.

Susana received a BS in Microbiology and PhD in Biosciences from The University of Texas at El Paso. Her dissertation focused on the use of alpha-Gal-containing neoglycoproteins as biomarkers and vaccine candidates for Chagas disease and Leishmaniasis. She is interested in immunology, with an emphasis in vaccinology, in vulnerable populations. 


CVD's T32 Program

Vaccines are one of the most cost-effective approaches in preventive medicine. The National Research Service Award T32 training grant is a unique opportunity designed to prepare MDs, PhDs, or those with equivalent degrees, for careers in vaccinology. Each T32 fellow selects the laboratory research track, clinical track, or combined laboratory and clinical track. The program offers all trainees broad exposure to both laboratory and clinical trial phases of vaccinology.

Program Administration

Executive Committee

Individuals interested in fellowship opportunities are encouraged to contact individual faculty and view faculty webpages.

Trainee Application Process

Eligibility /Qualifications:

Vaccinology Trainees will receive:

How to Apply:

Fill out the Application form...

Apply Now

If you do not meet the eligibility requirements for the T32, but would like to be considered for other post-doc training opportunities, please submit your CV to CVD_training@som.umaryland.edu.

For More Information:‌

Center for Vaccine Development and Global Health
University of Maryland School of Medicine
685 W. Baltimore Street, Room 480
Baltimore, MD 21201
+1 (410) 706-5328
CVD_training@som.umaryland.edu